Factory 99% Spectinomycin HCl Powder CAS 21736-83-4 Veterinary Spectinomycin HCl

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A562
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Spectinomycin HCl
• CAS: 21736-83-4
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Veterinary
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Spectinomycin HCl
Appearance	White Powder
CAS NO.	21736-83-4
MF	C18H36N6O7S2·HCl
Storage	Keep in a cool, dry, dark location

 

Spectinomycin HCl is a broad-spectrum antibacterial agent that belongs to the aminoglycoside class of antibiotics. It is characterized by its ability to inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby disrupting bacterial growth and replication.

 

1. Treatment of Gonorrhea: Spectinomycin HCl is primarily used for the treatment of uncomplicated gonococcal infections, particularly in cases where penicillin or other first-line antibiotics are not suitable or have failed.
2. Alternative Therapy: It serves as an alternative therapeutic option for patients with allergies or intolerances to other antibiotics commonly used for gonorrhea treatment.
3. Veterinary Medicine: In addition to human use, spectinomycin HCl is also employed in veterinary medicine for the treatment of certain bacterial infections in animals.

1. Bactericidal Activity: Spectinomycin HCl exhibits bactericidal activity against a range of Gram-negative bacteria, including Neisseria gonorrhoeae, the causative agent of gonorrhea.
2. Specificity: It has a relatively narrow spectrum of activity compared to other aminoglycosides, targeting specific bacterial strains and minimizing the risk of disrupting beneficial gut flora.
3. Minimal Side Effects: Spectinomycin HCl generally has minimal side effects, such as gastrointestinal discomfort or injection site reactions, making it a well-tolerated treatment option for many patients.